An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.

A new physiological pharmacokinetic model was used to explore the effect of exposure rate on the rate of formation of several crucial metabolites of benzene. Metabolite formation was compared following exposure to benzene over the course of an 8-hr workday and following a single exposure for 15 min. These exposures were based on the permissible exposure limit and short-term exposure limit of the benzene standard set by the Occupational Safety and Health Administration. The model was parametrized using in vitro and in vivo experimental data on benzene toxicokinetics and metabolism. Ranges, rather than fixed values, were assigned to the parameters. Model predictions show that the amounts of hydroquinone, catechol, and muconaldehyde formed in the body following a peak exposure to 32 ppm of benzene over 15 min are on average 20% higher than those formed following an equivalent dose of 1 ppm over an 8-hr period. The health consequences of these findings and the implications for policy concerning short-term exposure limits are discussed.

[1]  F Y Bois,et al.  Precision and sensitivity of pharmacokinetic models for cancer risk assessment: tetrachloroethylene in mice, rats, and humans. , 1990, Toxicology and applied pharmacology.

[2]  William H. Press,et al.  Numerical recipes , 1990 .

[3]  R. Henderson,et al.  A high pressure liquid chromatographic method for the separation and quantitation of water-soluble radiolabeled benzene metabolites. , 1988, Analytical biochemistry.

[4]  G F Kalf,et al.  Recent advances in the metabolism and toxicity of benzene. , 1987, Critical reviews in toxicology.

[5]  R. A. Neal,et al.  Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. , 1983, Molecular pharmacology.

[6]  S. Rappaport.  Smoothing of exposure variability at the receptor: implications for health standards. , 1985, Annals of Occupational Hygiene.

[7]  L S Birnbaum,et al.  Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice. , 1988, Toxicology and applied pharmacology.

[8]  R D Irons,et al.  Benzene disposition in the rat after exposure by inhalation. , 1979, Toxicology and applied pharmacology.

[9]  L S Birnbaum,et al.  Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. , 1989, Toxicology and applied pharmacology.

[10]  B. Allen,et al.  Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output. , 1989, Toxicology letters.

[11]  R. Zielhuis,et al.  Short-term occupational exposure limits: a simplified approach , 1988, International archives of occupational and environmental health.

[12]  R D Irons,et al.  An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. , 1987, Toxicology and applied pharmacology.

[13]  Technological, economic, and political feasibility in OSHA's Air Contaminants Standard. , 1991, Journal of health politics, policy and law.

[14]  I. Barrai,et al.  Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. , 1990, Mutation research.

[15]  R C Spear,et al.  Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications. , 1991, Risk analysis : an official publication of the Society for Risk Analysis.

[16]  L S Birnbaum,et al.  Effect of dose on the absorption and excretion of [14C]benzene administered orally or by inhalation in rats and mice. , 1987, Toxicology and applied pharmacology.

[17]  C J Portier,et al.  Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[18]  R C Spear,et al.  Comparison of three physiologically based pharmacokinetic models of benzene disposition. , 1991, Toxicology and applied pharmacology.

[19]  J. Houston,et al.  In vivo capacity of hepatic and extrahepatic enzymes to conjugate phenol. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[20]  Christopher J. Portier,et al.  Variability of safe dose estimates when using complicated models of the carcinogenic process. A case study: methylene chloride. , 1989 .

[21]  R C Spear,et al.  Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism. , 1991, Toxicology letters.

[22]  R. Spear,et al.  Physiological damping of exposure variability during brief periods. , 1988, The Annals of occupational hygiene.

[23]  D. Koop,et al.  Identification of ethanol-inducible P450 isozyme 3a (P450IIE1) as a benzene and phenol hydroxylase. , 1989, Toxicology and applied pharmacology.

[24]  W. Jakoby,et al.  Phenol sulfotransferases. , 1979, The Journal of biological chemistry.

[25]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[26]  V. Fiserova-Bergerova,et al.  Effects of biosolubility on pulmonary uptake and disposition of gases and vapors of lipophilic chemicals. , 1984, Drug metabolism reviews.

[27]  J. Houston,et al.  In vivo assessment of extrahepatic conjugative metabolism in first pass effects using the model compound phenol , 1980, The Journal of pharmacy and pharmacology.

[28]  D Hattis,et al.  Pharmacokinetic principles for dose-rate extrapolation of carcinogenic risk from genetically active agents. , 1990, Risk analysis : an official publication of the Society for Risk Analysis.

[29]  D. Eastmond,et al.  Two benzene metabolites, catechol and hydroquinone, produce a synergistic induction of micronuclei and toxicity in cultured human lymphocytes. , 1991, Mutation research.

[30]  S. Rappaport,et al.  Analysis of OSHA's short-term-exposure limit for benzene. , 1990, Regulatory toxicology and pharmacology : RTP.

[31]  R. Snyder,et al.  Comparison of the metabolism of benzene and its metabolite phenol in rat liver microsomes. , 1986, Advances in experimental medicine and biology.

[32]  D. Jerina,et al.  Arene oxides: a new aspect of drug metabolism. , 1974, Science.